Pharmacy Podcast Network
Original podcast
Where to listenCopy share link
How Kroger does PBM and the future of community pharmacy is clinical encounters.
6,296 words · 4 speakers
Thanks for listening to the Pharmacy Podcast Network.
Welcome to the PBM Reform Podcast, where we dive deep into the world of pharmaceutical benefit management, cutting through the noise to uncover the truth. Since 2019, we've been your go-to source for the latest on how PBMs impact patient care, drug pricing, and the very future of pharmacy. Here, we champion the role of pharmacists, the most knowledgeable advocates for medication safety and expertise. Join us as we expose and generate discussions that are reshaping healthcare and explore how we build a better payment system which focuses on advancing pharmacy care.
Well, welcome everybody to the PBM Reform Podcast here on the Pharmacy Podcast Network. My name is Brett Rice. I'll be your host today, and it's been my privilege to work with community pharmacies now for over 20 years. I love the industry, and it's been a great, a great time to work with fantastic pharmacists and community pharmacies across the country. And today, I have the honor and privilege to speak with one of those farm Ds and someone that, that I've been following a lot of their posts and, and seeing what differences they're making in the industry. So, welcome to the program, Dr. Jim Kirby.
Hi, thanks, Breck, for having me.
Yeah, so if you, I think most people know who Dr. Kirby is, but you're the chief commercial officer for Kroger Health. And I wanted to jump into a little bit of your, you as a person first, before we get into what you do and the work that you do at Kroger Health. So, Jim, where did you grow up?
We're going way back, back to the beginning. So, I grew up in northeast Ohio, North Canton specifically. So, Pro Football Hall of Fame is the, the claim to, the fame, I guess, of what put Canton, Ohio on the, on the map. And went to school at Ohio State to get my pharmacy degree. Back then, I think it was only Ohio State. They added the B sometime later after I graduated. And then eventually made it down here to Cincinnati and was the last post BS Pharm D class in the, in the state at the University of Cincinnati. And met my wife in that program and we settled here and rest is history.
Yeah, now, is your wife also a pharmacist?
She is. She is director of ambulatory care at Mercy West Hospital.
Okay, excellent, excellent. Keep, keeping it in the family. And so, when you, when you were growing up, did you know you always wanted to be a pharmacist? How did that come about?
Uh, man, I had, I had no idea what I wanted to do when I grew up. And thankfully, I had a father that he helped guide me in the things that I shouldn't do when I, when I grow up. And so, I was like, I want to maybe be a psychologist. And he was like, well, how long do you have to go to school for that? And what are you going to do with that degree? And, you know, I've got people that have psychology degrees that work on the, in the paper plant with me, or they drive truck. And so, you don't need to go to college and go into all this debt to do that. And I said, well, what about, you know, being in sociology? And he's kind of like same, same, same sort of argument.
So he was really pushing me to think about the, I guess, the, the financial health of my future and, and going, getting into a career that would allow me to be out of debt from student loans, but also be able to contribute back to society. So I ended up still pursuing psychology classes for a time at Ohio State and had a bio psych class that I loved learning about the action of neurotransmitters in the brain and how that influenced depression and anxiety and, and all those sorts of things. And I ended up landing in pharmacy school. But the, the kind of interesting part was, is even though I was very interested in pharmacy,
I went to pharmacy school and I never had my heart set on practicing pharmacy, that I would practice law and I was just going to graduate with pharmacy degree just to get me into law school. But that didn't end up happening either. And again, I think I can attribute that back to my dad as well. He said, well, what are you going to do with the law degree? And how much more years of school is that? And how much more debt you're going to be in? And, and so that kind of aided me and I had taken the LSAT, got into a couple of schools. But it was really during the time I graduated, I still had to finish some grad intern hours and I worked at CBS. And I had never worked in a community pharmacy before. All my intern hours were at a hospital.
And that's really where I fell in love with, with pharmacy again, just dealing with all the craziness of the public. I, I thrived on it. I thrived on interacting with people and getting to know them a bit more. So that combined with my dad's advice not to pursue law is like, you know, if I go down that path, law is going to supersede anything with pharmacy. So I think I'm going to stick with pharmacy and then ended up pursuing a, a farm D down at UC.
Yeah. So did you have, grew up with siblings that were your only child?
I have a younger brother. He's in the food business.
Okay. Did your dad give him as much counsel as he gave you?
I don't know. I think he got off a lot easier.
Yeah, those younger kids. I'm the youngest in my family. You know, they get away with everything, right?
Yeah, so, well, do you think it was your father who influenced you most growing up? Or what was your major influence growing up?
Well, I was the first person in my family to go to college. So I would say I had probably, he was probably one of the major influences in my life. And also I had a very tight group of friends that we all went to Ohio State together. And then we all stayed close. And one of them is also a pharmacist. He graduated the year after me. And the other two guys do very different things and live in different parts of the country. But we were pretty tight. And so that was, I would say, very formative in my early days as well, having those relationships.
Okay, yeah. Did you grow up playing sports? Were you in music, acting? What were your extracurriculars?
No, I did a little bit of acting.
But singing definitely was not for me or for anyone else that would listen to me. I was more interested in technology and computers. And I remember, you know, now I'm really dating myself of like the first Atari computer, not the Atari 800 that you played Space Invaders on, but like the Atari computer. And then I built my first computer at home. And so I was really into programming and those sorts of things. So really a nerd at heart. I loved Latin, too.
Excelled in that and participated in some different competitions for Latin scholarship. So that was, now I'm really making myself sound like a nerd. But those were kind of the fun things I enjoyed, as well as playing backyard football and stuff with my friends. But didn't ever do any high school structured sports.
Okay, all right. So got your farm D. You started, I guess you interned at a chain. So you saw the retail side. And then where'd you go from there in your career? And how did you end up landing at Kroger?
So one of my buddies that was in pharmacy school with me, he was from Columbus. And so he had kind of had it with with being in Columbus, wanted to do something different, but he wanted to stay in Ohio, within driving distance of his aging parents. So he said, hey, I'm gonna move either to Cleveland or Cincinnati, you wanna come? And I was like, sure, I'd be open to either one. I mean, Cleveland is only an hour from my parents and Cincinnati would be three and a half. So I was like, either one. And so he's like, great, I've got a interview with Drug Emporium down in Cincinnati, would you like to come? So I mean, this was like, predated the Step Brothers movie where they had dual interviews. And I feel like that's exactly what we did.
Interviewed together for jobs. And because I had worked at CVS with the drive-through, Drug Emporium was opened up a brand-new store format that was focused on holistic care, supplements, and vitamins, that they, much bigger expanded set that they normally had. And they had a drive-through that they wanted somebody with some level of experience. And so my short time at CVS qualified me to manage that store. And then my buddy got a job as a stat pharmacist at a different Drug Emporium. So that's what initially brought me to Cincinnati and really built that business from the ground up.
I had to do doctor detailing and do health fairs across the city of Mason, here north of Cincinnati, and really learned the alternative complementary medicine side of the business too, and interactions with pharmaceuticals and whatnot. So it was a great, great learning experience all around. And then I ended up going back, as I said, and got my Pharm D from there. So I was very fortunate to be given those kind of amazing opportunities that one thing led to another.
Yeah, so Drug Emporium, are they still around today? Are they been acquired? What's the status?
They are gone. They both closed down shop. And when I was in Farm D's school, they were really pushing me. UC was great because it was a very small program. Only 14 were in my class. And then we had to track in Farm D's that were coming in. It's just the advent of the all Farm D curriculum. But the dean and the assistant dean and the chair were all very invested in my future and all of our futures and what we were going to do. And the thing that they had kept talking to me about was clinical pharmacy in the community. They said there needs to be a focus on delivering clinical services in a community pharmacy setting.
It can't just be about putting pills in a bottle. And they said that I would be perfect to lead that effort and that there was a connection at Kroger and that they wanted to have kind of a shared faculty position, but they wanted to be a full-time employee of Kroger. And so it was a new position that they were developing and that's what they wanted me to pursue. I wasn't exactly sold. I was going to do a residency and had applied to some different programs, but at the end of the day, I ended up choosing the Kroger route.
Yeah. So now, how many years have you been with Kroger?
Let's see. This will be about 24 years in, well, 22 years over a 24-year period. I actually left Kroger in the middle there and helped start Anthem Specialty Pharmacy. It was called Precision RX Specialty Solutions. It was a subsidiary of their PBM, NextRx, and did that for a couple of years. And the business grew as we were bringing all the WellPoint plans into the specialty pharmacy world. We relocated to Indianapolis and I was commuting back and forth for a while. And I had an offer to move and determined that... My wife and I were having, starting a family here and we didn't want to relocate to Indianapolis.
So I did that for a while and then eventually came crawling back on my hands and knees to Kroger for a job and started back in the division office again and seeing patients in some of the programs I had started the first time around and then ended up then managing those programs, going into the division office as the clinical manager and then came here to general office in 2013.
Okay, yeah, great, great career and a long time with, with a great company and worked your way up the food chain now to, you know, chief, chief commercial officer there. And so tell me exactly what is your stewardship then as, as, you know, that's pretty a broad title, right? Chief Commercial Officer. So what, what are your actual stewardships?
Yeah, and it's, it's evolved over the course of time. I would say that, you know, kind of like what I had described in my history, my, my overall broad charge is how do we advance community pharmacy practice and have our pharmacists and our technicians delivering care at the top of their licenses and, and putting the patient at the center while we improve outcomes at a, at a lower cost. Now, what does that mean for me specifically in my remit on a day-to-day basis? I'm in charge of the innovation and research. So what are the things that we need to be developing and thinking about for the next three years that are coming down the pike? I am in charge of professional affairs. So our, our relationships
with universities in particular, as well as nonprofits and trade associations, professional associations. I have responsibility for our PBM. I have responsibility for our Food for Health Initiative and then our business development and strategic partnership team.
Okay. Well, we want to jump into the PBM side here because you are listening to the PBM Reform Podcast Series here on the Pharmacy Podcast Network. And so we wanted to learn more about Kroger's, your own solution to pharmacy benefit management. So tell us about your, your PBM.
Sure. So it was started, I have to go back, I think it was started in 1997. And it may even be earlier than that, I may have that year wrong, but it's been around for a long time. And it was created primarily for the purpose of serving our own associates to start. And in Kroger is organized, we have about, give or take, 450,000 or so employees. And some of those are managed underneath the consolidated benefit. And some of them are called non-consolidated, which are like the Tap Hartley Union Plans. And we've got about 100 and, we'll say, 150,000 lives or so that are underneath that consolidated benefit plan.
So this is your management group, your store managers, your general office and corporate folks fall underneath of that. So the PBM started with managing benefits for that consolidated group. And then, just like with any other employer, you have to win lives with the Tap Hartley groups. Even though they're supporting Kroger, they may also be supporting other companies as well. Like the Meat Cutters may have different retailers that are in that union group. So you have to go and bid and win those groups. So we were successful in winning some of those groups. We don't have all of them, but we have a portion of them. And that's really where Kroger Prescription Plans stabilized itself for a number of years.
And then eventually it started to kind of spread its wings a little bit and serve as a solution for other self-insured employers, particularly smaller ones. I would say our clients range anywhere from, you know, as small as maybe 50 to, you know, the size of the Kroger company is our largest client. But those small companies that really needed to have or wanted to have portable benefits for their employees but not have to go fully insured, this was a really nice option for them. And so we've grown now to, you know, about 90 different clients, I'd say, in addition to our own.
Kroger employees and that's who we service.
Yeah, okay, excellent. And what do you think differentiates your pharmacy benefits versus a big, one of the big three that everyone hears about, you know, the Optum's, the Express scripts and Caremark?
Yeah, I think that there's, you know, there's a lot of anti-PBM rhetoric that's going on in the industry and there's a lot of movement towards reform and I am certainly for reform. I mean, given my history as a community pharmacy leader and innovator, I would be a hypocrite if I didn't think that there needed to be some reform in the PBM world. But I'm also not to the camp where I have my torch out, my pitchfork and say, PBMs are the devil and they need to all go away. They perform a necessary service in allowing pharmacies electronically adjudicate and receive real-time payment for prescriptions.
They've just gotten, you know, maybe a little bit out over their skis in the way that they try to make money and create value to their upstream plans and take value from their lower stream providers, AKA the pharmacies. And obviously, there's issues with transparency in payments and the games that the PBMs play with getting you on definitions and rotating MAC lists and so on and so forth. And so I would say that PBMs aren't evil Brek in of themselves. I think some of the practices that they typically use to create profitability
for themselves or value for their clients is where the issue really lies. So we want to be above all of that. You know, we have to operate as a PBM, but we're not going to play the games. We're not going to try to screw pharmacies out of their, out of fair and reasonable reimbursement. So I think that's probably the biggest, you know, foundational point that I want to make is that.
Transparency and fairness is absolutely key. But now, I think we've come to a place where many PBMs are, you know, using those same terms and they've also, they've almost become euphemisms. And, you know, everyone claims that they're fair and transparent and what does that really mean? They're fair and transparent to the extent that they're willing to share with you those fees or those, um, uh, those ways in which they calculate reimbursements and those sorts of things. But are they really? That's really the question. So what we're trying to do is, is, is really change the game and not just by paying pharmacies
fairly, but also getting pharmacies to do clinical interventions for our clients and selling our clients for the ability of what pharmacies can do for them to reduce drug costs, but, um, but also to better manage outcomes. So like for our, you know, for Kroger pharmacies in general, I'll just speak to this versus the, you know, pharmacies that we don't own. Uh, our Kroger pharmacies do more than 5 million clinical interventions a year. And that's not drug utilization review. That's just, and that's just not for KPP either. That's for all of our, our book of business that Kroger Pharmacy has.
Uh, but KPP, uh, pays Kroger pharmacies to do those services. The manage adherence, extended day supplies, CMRs, um, suboptimal drug use, even, uh, loxone prescribing for high-risk opioid prescriptions. So really the gamut of, of clinical services by, uh, by a pharmacy. And we pay for diabetes management and hypertension management too. Those programs, we've had a couple of different iterations of those programs over the course of time. So that's one thing that we want to stand by is the power of community pharmacy. And, and if I look ahead of where we want to go is we want to look at how do we now
take the access of our membership at KPP to Kroger pharmacies and other pharmacies that can provide a similar or standard service set.
And bring food into the picture as well and and really look at the holistic and social determinants of of health needs for our membership and bringing that opportunity to our employer base to say like, let's, let's forget about PBM profits. We don't even need to be thinking about that. Let's just talk about the membership and how do we use these pharmacies that are in a, we'll call it a pseudo clinically integrated network to deliver the right interventions at the right time to be thinking about food, transportation, and these other benefits to deliver for you a healthier member population that's contributing
to your bottom line. What if PBM profits weren't even on the table? You think about fees and cost plus, like, what if we just took those all off the table and you took those savings and invested in your associates in that way? Would that be of interest to you? And I think that's the game changer. I think that PBMs go back to what the PBMs are supposed to do, just, you know, provide a service, but you instead focus on the interactions that you have with the patients to improve outcomes and costs. That's the power of of the PBM with the community pharmacy.
Yeah. And Dr. Kirby, that's what caught my attention about you when you started talking about that, when that very thing that you just covered and how food could be medicine and how, you know, we, we're, we should change the focus on preventative instead of reactive. That really caught my attention. I thought, man, you're on to something. That's what I think all community pharmacies should be focused on is what can we do for prevention wise versus just being a dispensary? And that's very reactive, right? We could do a whole another podcast series just on that. But, you know, keeping in the theme here
of PBM, it does make sense personally to me to take care of your own employees, right? You have your own pharmacies, you have your own employees. My company, even though we only do workers comp, right? We don't do any of the commercial plans and workers comp is only like 1% of all those claims. But still, it's so much easier to do that for our own clients who have their own pharmacies, right? In fact, we help a large hospital system out west. Just straight pass through where if a nurse accidentally gets a needle stick, that's a pretty costly drug, drug therapy that they have to go on to protect them from, you know, all the blood diseases, HIV, hepatitis, et cetera.
And it's a pretty expensive therapy. Well, we do a straight pass through. It's that, you know, employer or that hospital, patient at that hospital's pharmacy. It's the straight cost of the, of the medication. You know, it's got to save them millions of dollars a year, right? So I can see that benefit doing the program that you started out to do for your own employees, Kroger's employees. But now for these self insured companies that don't own their own pharmacies, you hope they use your pharmacy, but they could go to any pharmacy, right? How do, how do you price that and still make it work out for a cost containment for the employer, but still a fair reimbursement to the pharmacy?
Yeah, I mean, in today's world and in the traditional PBM employer relationship, that, that has, your, your cost of your wrap network is, is built in to the, the overall pricing that you're, you're giving. We don't favor Kroger pharmacies over and pay them differently than what we would pay other pharmacies. I think that that has to be, you know, rule number one. But if an employer is, is choosing a preferred or an exclusive network, obviously there's different benefits that are conferred based upon that. And that's where I, you know, I'm trying to drive towards to say like, what if, like here in Cincinnati, we're, we're based and, you know, we have.
High market share within Kroger here in Cincinnati. Why wouldn't any other local employer here in Cincinnati not want to use Kroger Pharmacy in the Kroger store if, you know, they were getting these additional benefits like food stipends and clinical services at the pharmacy? It makes all the sense in the world and it basically functions like they are an owned entity, like they are treating their own associates, just like we treat our own associates. So I think that's really where we have the right to win is in the place where we have market share within the stores. But I think this goes, and I have a vision that it's not just about Kroger and it's
not just about where we have market share, that if you pick any other competitor, I'm not going to say them by name, but if they agree to a standard service set and agree to deliver certain outcomes and that we're measuring it in the same way as Kroger pharmacies are, whether they have food or whether they don't, now if they have food, then I kind of have to apply the same thing, like are they measuring the nutrition of the purchases in the same way that we are so we can aggregate the data? But you can create this cross-organizational clinically-integrated network across different competitors and you could do the same thing then nationally than you could in a highly concentrated Kroger market.
Yeah, yeah, absolutely. How do you handle reporting? Is there a pretty robust communication channel between you and your clients on reporting those very measures that you're tracking?
Yes. I mean, there's detailed reports on the clinical programs from utilization and success rate to the outcome measures, but then also on the more traditional PBM side, I would say that we have, in other PBMs that are small or boutique, I think this is where they kind of stand apart too, is that they have very specific drug level reporting in which they typically don't get that kind of information from the big three.
Right. How does your PBM handle rebates?
I mean, really, that's up to the employer. You still have employers that like to focus on rebates because that's part of the way that they built their P and L. Is built on that. Then you have others that want the lowest absolute net cost. We try to, again, in the in the spirit of transparency and education, we try to take a higher road approach, I guess, with our employers and let them know, like, here are the different scenarios that you might be considering, and here's the pros and cons of this. We like to recommend the lowest net cost.
Now, that doesn't mean necessarily, you know, in the case of specialty pharmacy, only biosimilars. I think what it does is it takes into account, like, lowest net cost would be consideration of what the expected rebates would be, what the expected conversion rate and adoption rate of a particular formula choice would be. And we try to, you know, walk hand in hand with the employer to educate them on what's realistic, what are their goals, and how do we achieve the lowest net costs for the most clinically integrated, most clinically efficacious product? I think that's, that's really the key. But you've got, I mean, we've, we've tested the market, and the games that are being
shared with employers are really heartbreaking, that they'll put in all sorts of guarantees and assumptions that, you know, the GLP-1 growth will go by 100%, and it's, you know, these different things that, assumptions that maybe an HR leader doesn't fully have the awareness or understanding whether that prediction or those guarantees are going to be real or not. But when we look at it, and we're like, this is, this is insane, we're not gonna, we're not gonna play these games. And we try to look and price where it's going to be in real time when we would have the business versus, you know, looking at claims files that are two years old and making assumptions that are outdated or just altogether wrong, and trying to win the business based on that.
We're trying to win the business based on, on reality.
Yeah. So with that in mind, then how do you handle formularies? You know, it sounds like there's a lot of consultation to try to get to the lowest cost, but you know, formularies can come into effect where you're also trying to provide the best clinical solution as well.
Yep. Well, clinical is always first. And so we have a P and T committee that's made up of physicians across the region in different health systems and different specialties so that we have a good representation within each therapeutic category. And they'll review the, our formulary pharmacy team will present information to them on a quarterly basis and they'll review all the clinical data and make recommendations. And then, then we apply the economic assessment of how this will affect rebates and, and overall net costs of the, of the formulary within that particular condition. So it's definitely
a balanced clinical is always first, but it operates very much like a hospital P and T where you have the clinical and then the value assessment.
Okay. And can your clients see a complete list of the formulary?
Yep. And there's different formularies that they can choose from.
Okay. Excellent. And then, so I'm glad that you mentioned that, that the, you know, first clinical is first and then you look at the, at the cost. And so we see, you know, I think that's one of the, the bad wraps of PBMs today is that, you know, you, and it's always the outliers, right? One patient couldn't get one medication, but you know, 200,000 patients are getting a formulary medication that's working just fine, but you hear that squeaky will not being able to get their one medication because it was
on, not on formulary. So glad that you take that approach. What additional, you know, data or reporting you think sets you apart from, you know, from the big three PBMs?
Well, I mentioned about the certainly the rebate reporting and getting level down to a level of specificity that they big three typically don't and there's also a level of data and reporting that's provided in order for us to be consultative in helping them think about a particular formulary, think about formulary changes that we would maybe ask them or recommend that they make or clinical programs that we would ask them to be involved with. But I think the other thing that gets really interesting is when you have employers that will give us access to the medical data and combine that then
with our prescription claims data and then that becomes a very rich opportunity for us to make more intelligent recommendations and, you know, new recommendations that we maybe otherwise wouldn't have purview into. So that's a key thing, not from a, your question was more output directed, but even from an input direction, I think that's maybe a differentiator too, is we start to think about the food and purchase data and the medical claims data and the pharmacy data, the more data sets that we have available to us, the better and differentiated service we can provide.
Yeah, and that was a good lead in to my next question was how fluid is, you know, the opportunity for a client to go in mid-year and make adjustments and changes based on maybe more evidence that's now being gathered?
Sure, quarterly. Quarterly is generally, because you have to have some sort of structured cadence so that you're not just going at will and things are just changing midstream and people don't know what end is up. But clients have the opportunity to make changes and we regularly make changes on a quarterly basis.
Do you have some kind of a peel process for that one-off when your patient really is feeling like they need a name brand, but the, you know, the generic is on formulary?
Yeah, we, our clinical team reviews all level, all appeals, all level two reviews and all appeals. So there is the opportunity to look at, you know, what is the, this patient's unique case? Why did they need this non-formulary drug? Do they have, you know, allergies to the other, the other drugs in the class? Have they tried it and they failed? What's going on here? So there is that, um, uh, there is that process put in place. And in fact, when I came to general office, I was that formulary review, or not part of the PA review pharmacist for KPP. So I got, it was hard because, you know, I had a bleeding heart. I'm like, well, of course
we're going to approve this. They need access. It's, you know, that's, it's a community provider. That's, you're always kind of your, your, your first point of view is how do you get this patient their drug versus on the plan side, you're looking at, oh, you know, what's the cost? What's the other ramifications here? So I think that balance that we have with Croker prescription plans, like with myself now leading it, uh, of pharmacists thinking like community pharmacy providers, but doing it with the plan fiduciary interest in mind.
Wow, that's excellent. Well, is there anything, Dr. Kirby, that we haven't discussed that you think is important that we should let our listeners know about?
Um, I think we touched on most of the things. I would say that, you know, for the listeners and my fellow pharmacists out there is that I would say a couple of things. One is I would find ways to work with PBMs and, and challenge them on, on what you can do to improve the care of their, of their membership. They're open and looking and oftentimes they're looking to digital or virtual solutions for diabetes management, hypertension management. But our staffs are more than equipped to be able to do those sorts of things and deliver, I would say, better outcomes because of the longitudinal relationships that we have and exist more than just in a, in a digital or virtual, a virtual ecosystem. So that's
That's one thing. And the second thing I would say is stand your ground on things that should be managed by the pharmacist as providers and not taken by the PBM. So, for instance, medical billing for test to treat services and chronic disease management services, you know, I just use that as an example that you could work with the PBM on and bill as a B2B service provider. But you could also, you know, particularly as we move forward in with provider status in certain states or just, you know, being considered as such by the payer, billing those encounters on the medical benefit
and getting into the medical networks and dealing directly with the upstream plan is absolutely key. And you've got several PBMs that are trying to insert themselves in that space and bill those medical clinical encounters as a NCPTP transaction. And I think that that's completely inappropriate. We are providers, we are clinicians, and we need to act like the rest of the provider community and become providers in the medical networks, bill as such, and not allow the PBMs to negotiate on our behalf.
Very well said. And I'm glad that you brought that up. That's a key point. A lot of community pharmacies and, you know, grocery store chains and others are looking to how to expand their scope of services into more clinical. And for me, it's, you know, another way to bypass the poor reimbursements of just dispensing the medication and offering more services to your patients. And it's going to make those patients more sticky to you if you're providing those additional services as a community pharmacist. Well, some rapid fire questions for you real quick, Jim. Just first thing comes to mind. You ready? Are you an early bird or a night owl?
Uh, neither? How about that?
Depends on the circumstance.
That's right. If it's, if there's bourbon involved, then maybe late night. But on a given work, work day, I like to, to rise early and have my alone time.
Yeah, okay. Excellent. And then are you, do you prefer the mountains or the beach?
Mountains.
Okay. And are you, uh, do you prefer coffee, tea, or something else?
Coffee. Stronger the better.
Okay.
If you can kill a small rodent, that's the type of coffee I like.
Your spoon stands up in it, right?
Exactly.
Excellent. So, well, thank you, Dr. Kirby, for being our guest today on the PBM Reform Podcast. It was great to get to know you a little better, and I hope that this has been educational to a lot of our listeners today. So, thanks again for being here. And you have been listening to the PBM Reform Podcast here on the Pharmacy Podcast Network. Thanks, everyone.
Page updated November 14, 2026 · transcript and summary are machine-generated